| Financial Year |
September 30 2020 |
| Monetary Funds |
198,570,504.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,766,167.50 |
| Accounts Receivable |
2,365,909,531.91 |
| Advances to Suppliers |
189,536,793.51 |
| Other Receivables |
1,644,664,832.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
22,867,640.65 |
| Dividend Receivable |
-- |
| Inventories |
1,620,534,463.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,343,000.00 |
| Other Current Assets |
575,799,207.21 |
| Total Current Assets |
6,605,124,501.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
130,111,451.71 |
| Long-term Equity Investment |
66,953,914.22 |
| Investment Properties |
-- |
| Fixed Assetes |
15,676,584,009.93 |
| Under-construction Projects |
3,985,075,263.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
42,447,187.91 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,096,936,180.62 |
| R&D expenses |
-- |
| Goodwill |
53,086,251.07 |
| Long-Term Deferred and Prepaid Expenses |
127,314,458.04 |
| Deferred Income Tax Assets |
106,264,970.18 |
| Other Non-Current Assets |
2,005,163,909.25 |
| Sub-Total of Non-Current Assets |
23,336,955,904.85 |
| Total Assets |
29,942,080,405.86 |
| Short-Term Loans |
4,282,386,339.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
4,720,800,644.20 |
| Accounts Received In Advance |
4,651,307.96 |
| Employee Compensation Payable |
390,303,734.40 |
| Taxes Payable |
328,831,286.26 |
| Interest Payable |
4,271,772,413.26 |
| Dividend Payable |
4,429,843.64 |
| Other payables |
9,642,149,550.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,515,131,071.95 |
| Other Current Liabilities |
15,617,295.55 |
| Sub-Total of Current Liabilities |
28,899,871,229.99 |
| Long-term Loans |
1,959,930,118.76 |
| Bonds Payable |
199,079,057.55 |
| Long-Term Accounts Payable |
2,458,446,625.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
89,586,175.51 |
| Other Non-Current Liabilities |
19,841,998.50 |
| Sub-Total of Non-Current Liabilities |
4,970,043,096.85 |
| Total Liabilities |
33,869,914,326.84 |
| Paid-In Capital(Or Share Stock) |
3,929,595,494.00 |
| Capital Surplus |
6,380,616,307.45 |
| Surplus Reserve |
237,311,633.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-14,167,216,953.27 |
| Minority Stockholder's Interest |
-322,598,841.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-3,605,235,079.07 |
| Owner's Equity（Stockholder's Equity） |
-3,927,833,920.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
29,942,080,405.86 |
